Octreotide LAR treatment of acromegaly in “real life”: long-term outcome at a tertiary care center

被引：0
|
作者：
Ana Laura Espinosa-de-los-Monteros
Baldomero Gonzalez
Guadalupe Vargas
Ernesto Sosa
Moises Mercado
机构：
[1] Instituto Mexicano del Seguro Social,Endocrinology Service, Experimental Endocrinology Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI
来源：
Pituitary | 2015年 / 18卷
关键词：
Acromegaly; Octreotide LAR; Somatostatin analogs; GH; IGF-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：290 / 296
页数：6
相关论文
共 50 条
  • [21] Long-term follow up of octreotide LAR in the treatment of metastasized midgut carcinoids.
    Ritzel, U
    Wietzke-Braun, P
    Leonhardt, U
    Ramadori, G
    GASTROENTEROLOGY, 2000, 118 (04) : A1408 - A1408
  • [22] Long-term outcome in treated acromegaly
    Webb, Susan M.
    Sucunza, Nuria
    Resmini, Eugenia
    Barahona, Maria Jose
    ENDOCRINE JOURNAL, 2010, 57 : S249 - S249
  • [23] Long-term effects of lanreotide SR and octreotide LAR® on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly
    Amato, G
    Mazziotti, G
    Rotondi, M
    Iorio, S
    Doga, M
    Sorvillo, F
    Manganella, G
    Di Salle, F
    Giustina, A
    Carella, C
    CLINICAL ENDOCRINOLOGY, 2002, 56 (01) : 65 - 71
  • [24] Long-term treatment outcomes of acromegaly patients presenting biochemically-uncontrolled at a tertiary pituitary center
    Carmichael, John D.
    Broder, Michael S.
    Cherepanov, Dasha
    Chang, Eunice
    Mamelak, Adam
    Said, Qayyim
    Neary, Maureen P.
    Bonert, Vivien
    BMC ENDOCRINE DISORDERS, 2017, 17
  • [25] Long-term treatment outcomes of acromegaly patients presenting biochemically-uncontrolled at a tertiary pituitary center
    John D. Carmichael
    Michael S. Broder
    Dasha Cherepanov
    Eunice Chang
    Adam Mamelak
    Qayyim Said
    Maureen P. Neary
    Vivien Bonert
    BMC Endocrine Disorders, 17
  • [26] Long-term therapy with long-acting octreotide (Sandostatin-LAR®) for the management of acromegaly (vol 48, pg 311, 1998)
    Davies, PH
    Stewart, SE
    Lancranjan, I
    Sheppard, MC
    Stewart, PM
    CLINICAL ENDOCRINOLOGY, 1998, 48 (05) : 673 - 673
  • [27] Long-term analgesic effect of octreotide on headache in patients with acromegaly
    Yokoyama, S
    Hirano, H
    Tajitsu, K
    Kusumoto, K
    CEPHALALGIA, 2005, 25 (10) : 910 - 910
  • [28] LONG-TERM EFFECT OF OCTREOTIDE IN ACROMEGALY ON INSULIN-RESISTANCE
    BREIDERT, M
    PINZER, T
    WILDBRETT, J
    BORNSTEIN, SR
    HANEFELD, M
    HORMONE AND METABOLIC RESEARCH, 1995, 27 (05) : 226 - 230
  • [29] LONG-TERM EFFECTS OF CONTINUOUS SUBCUTANEOUS INFUSION OF THE SOMATOSTATIN ANALOG OCTREOTIDE IN THE TREATMENT OF ACROMEGALY
    TAUBER, JP
    BABIN, T
    TAUBER, MT
    VIGONI, F
    BONAFE, A
    DUCASSE, M
    HARRIS, AG
    BAYARD, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (05): : 917 - 924
  • [30] Long-term Outcome Of Chronic Dialysis In A Tertiary Pediatric Center
    Erez, Daniella Levy
    Krause, Irit
    Dagan, Amit
    Falush, Yafa
    Cleper, Roxana
    Davidovits, Miriam
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1766 - 1767
12345